Literature DB >> 33680385

Comparison of ertapenem non-susceptibility with 2-mercaptopropionic acid phenotypic tests in predicting NDM-1 and IMP-1 production in clinical isolates of Escherichia coli.

Zahra Shahandeh1, Narges Kalantrai2, Farahnaz Sadighian1.   

Abstract

BACKGROUND: A routine phenotypic test has not been recommended for the detection of metallo-β-lactamases (MBLs) producing Enterobacteriaceae species such as Escherichia coli. The current study was conducted to compare the 2-mercaptopropionic acid (2-MPA) phenotypic method and ertapenem non-susceptibility test with polymerase chain reaction in predicting the production of MBLs in clinical isolates of E. coli.
METHODS: Antimicrobial susceptibility test for beta-lactam antibiotics were performed by disk diffusion method. All isolates which showed inhibition zones of ≤ 22 mm for CAZ and ≤ 27 mm for CTX were considered potential MBLs producing isolates. The production of MBLs was confirmed using 2-MPA compound. Also, susceptibility to ertapenem was evaluated in all isolates. Conventional PCR was performed to detect blaIMP-1 and/or blaNDM-1 genes in all potential MBLs producing E. coli isolates.
RESULTS: Of 259, 138 (53.3%) isolates were potential MBLs producing bacteria. One hundred and fifteen out of 138 (83.3%) isolates were susceptible to ertapenem. MBLs production was confirmed in 75/138 (54.4%) isolates by 2-MPA phenotypic method. The blaNDM-1 or/and blaIMP-1 genes were found in 30/75(40%) and 39/115(33.9%) isolates which were confirmed by 2-MPA and were susceptible to ertapenem, respectively. The sensitivity of 2-MPA method and ertapenem non-susceptibility test compared with PCR were 65.2% and 15.2%, and the specificity was 52.1% versus 82.6%, respectively.
CONCLUSION: This study demonstrated that the 2-MPA phenotypic method does not have acceptable sensitivity and specificity in comparison with PCR, but its results are more reliable for the detection of MBL producing E. coli isolates compared with non-susceptibility to ertapenem.
Copyright © 2020, Babol University of Medical Sciences.

Entities:  

Keywords:  2-MPA; E. coli; Ertapenem; blaIMP-1; blaNDM-1

Year:  2020        PMID: 33680385      PMCID: PMC7911768          DOI: 10.22088/cjim.11.4.426

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  20 in total

Review 1.  Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

Authors:  David M Livermore; Jenny M Andrews; Peter M Hawkey; Pak-Leung Ho; Yoram Keness; Yohei Doi; David Paterson; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2012-03-29       Impact factor: 5.790

Review 2.  Beta-lactamases in Enterobacteriaceae infections in children.

Authors:  Christopher Alan Moxon; Stéphane Paulus
Journal:  J Infect       Date:  2016-05-11       Impact factor: 6.072

3.  In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014.

Authors:  James A Karlowsky; Sibylle H Lob; Krystyna M Kazmierczak; Robert E Badal; Katherine Young; Mary R Motyl; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

4.  Carbapenem-Resistant Enterobactericeae: ClinicoEpidemiological Perspective.

Authors:  N A Mohamed; H M Said; H Hussin; N Abdul Rahman; R Hashim
Journal:  Trop Biomed       Date:  2018-06-01       Impact factor: 0.623

5.  [Comparison of phenotypic methods for the detection of beta-lactamases MBL in strains from the Enterobacteriaceae family and non-fermentative bacilli isolated from clinical specimens].

Authors:  Kornelia Dobrzaniecka; Andrzej Młynarczyk; Ksenia Szymanek-Majchrzak; Grazyna Młynarczyk
Journal:  Med Dosw Mikrobiol       Date:  2014

6.  Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.

Authors:  Amos Adler; Ma'ayan Ben-Dalak; Ina Chmelnitsky; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

7.  First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran.

Authors:  Fereshteh Shahcheraghi; Saman Nobari; Fatemeh Rahmati Ghezelgeh; Siavash Nasiri; Parviz Owlia; Vajihe Sadat Nikbin; Abbas Ali Imani Fooladi
Journal:  Microb Drug Resist       Date:  2012-09-17       Impact factor: 3.431

8.  Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.

Authors:  Gabriel Levy Hara; Ian Gould; Andrea Endimiani; Pilar Ramón Pardo; George Daikos; Po-Ren Hsueh; Shaheen Mehtar; George Petrikkos; José María Casellas; Lucía Daciuk; Daniela Paciel; Andrea Novelli; Raphael Saginur; Daniel Pryluka; Julio Medina; Eduardo Savio
Journal:  J Chemother       Date:  2013-06       Impact factor: 1.714

9.  New Delhi Metallo-Beta-Lactamase-Producing Enterobacteriaceae in South Korea Between 2010 and 2015.

Authors:  Eun-Jeong Yoon; Da Young Kang; Ji Woo Yang; Dokyun Kim; Hyukmin Lee; Kwang Jun Lee; Seok Hoon Jeong
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

10.  Comparison of clinical methods for detecting carbapenem-resistant Enterobacteriaceae.

Authors:  Kirsten Kost; Jumi Yi; Beverly Rogers; Robert Jerris
Journal:  Pract Lab Med       Date:  2017-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.